Acumen Pharmaceuticals, Inc. (ABOS)
Market Open
20 Jul, 17:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
2. 17
-0.08
-3.3333%
$
153.25M Market Cap
- P/E Ratio
- Div Yield
21,556 Volume
- Eps
$ 2.25
Previous Close 
Want to track ABOS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Acumen Pharmaceuticals, Inc. (ABOS) Statistics
Valuation metrics
Market Cap 153.25M
Enterprise value 115.66M
Trailing P/E (ttm) -1.2
Forward P/E -
PEG ratio 1.37
Price/Sales (ttm) -
Price/Book (mrq) 1.63
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.06
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 492.62K
Average volume (90 days) 350.49K
Price summary
52-Week low 1.19
52-Week high 3.6
Beta -
50-Day moving average 2.38
200-Day moving average 2.52
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.85%
Return on equity -1.23%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.79
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.03
Total debt (mrq) -
Total Debt/Equity (mrq) 0.36
Current ratio (mrq) 4.55%
Book value per share (mrq) 1.38
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
